179 related articles for article (PubMed ID: 36951394)
1. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
Hammond HH; Ames MK; Domenig O; Scansen BA; Yang NT; Wilson MD; Sunshine E; Brunk K; Masters A
J Vet Intern Med; 2023; 37(3):875-886. PubMed ID: 36951394
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Ames MK; Atkins CE; Eriksson A; Hess AM
J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
Galizzi A; Bagardi M; Stranieri A; Zanaboni AM; Malchiodi D; Borromeo V; Brambilla PG; Locatelli C
BMC Vet Res; 2021 Jan; 17(1):15. PubMed ID: 33413406
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.
Newhard DK; Jung S; Winter RL; Duran SH
J Vet Intern Med; 2018 Sep; 32(5):1555-1563. PubMed ID: 30084228
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
Druzhaeva N; Nemec Svete A; Ihan A; Pohar K; Domanjko Petrič A
J Vet Intern Med; 2021 Sep; 35(5):2112-2122. PubMed ID: 34236111
[TBL] [Abstract][Full Text] [Related]
7. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
8. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of urinary neutrophil gelatinase-associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease.
Troia R; Sabetti MC; Crosara S; Quintavalla C; Romito G; Mazzoldi C; Fidanzio F; Cescatti M; Bertazzolo W; Giunti M; Dondi F
J Vet Intern Med; 2022 Nov; 36(6):2053-2062. PubMed ID: 36196592
[TBL] [Abstract][Full Text] [Related]
10. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
Li Q; Freeman LM; Rush JE; Laflamme DP
Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
[TBL] [Abstract][Full Text] [Related]
11. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
[TBL] [Abstract][Full Text] [Related]
12. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
Zhou Q; Wu Z; Li L; Zhou H; Chen Y; Guo S; Guo Y; Ma X; Zhang J; Feng W; Cui X; Qiu C; Xu M; Deng G
J Proteomics; 2023 Jun; 282():104924. PubMed ID: 37146676
[TBL] [Abstract][Full Text] [Related]
13. Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.
Adin D; Kurtz K; Atkins C; Papich MG; Vaden S
J Vet Intern Med; 2020 Jan; 34(1):53-64. PubMed ID: 31769114
[TBL] [Abstract][Full Text] [Related]
14. Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.
Cheng CJ; Mandour AS; Yoshida T; Watari T; Tanaka R; Matsuura K
J Vet Intern Med; 2022 Mar; 36(2):397-405. PubMed ID: 34994485
[TBL] [Abstract][Full Text] [Related]
15. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
Lee CM; Jeong DM; Kang MH; Kim SG; Han JI; Park HM
Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
[TBL] [Abstract][Full Text] [Related]
16. Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.
Larouche-Lebel É; Loughran KA; Oyama MA; Solter PF; Laughlin DS; Sánchez MD; Assenmacher CA; Fox PR; Fries RC
J Vet Intern Med; 2019 Jul; 33(4):1571-1584. PubMed ID: 31254308
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
Vereb M; Atkins CE; Adin D; Blondel T; Coffman M; Lee S; Guillot E; Ward JL
J Vet Intern Med; 2024; 38(1):51-60. PubMed ID: 37909399
[TBL] [Abstract][Full Text] [Related]
18. Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.
Reimann MJ; Häggström J; Mortensen A; Lykkesfeldt J; Møller JE; Falk T; Olsen LH
J Vet Intern Med; 2014; 28(5):1520-6. PubMed ID: 25274442
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics.
Franchini A; Borgarelli M; Abbott JA; Menciotti G; Crosara S; Häggström J; Lahmers S; Rosenthal S; Tyrrell W
J Vet Cardiol; 2022 Jun; 41():99-120. PubMed ID: 35316716
[TBL] [Abstract][Full Text] [Related]
20. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
Bagardi M; Ghilardi S; Zamarian V; Ceciliani F; Brambilla PG; Lecchi C
PLoS One; 2022; 17(7):e0266208. PubMed ID: 35816500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
